未登录

M

Marianne Schultzberg

karolinska institutet

H指数:65

被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The association of periodontal inflammation and inflammatory markers with cognitive dysfunction: A case–control study

牙周炎症和炎症标志物与认知功能障碍的关联：一项病例对照研究

Journal of Periodontology

IF3.8

2025-11-100

OAAI

Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health

阿尔茨海默病中的生物能量学与脂质代谢：从细胞生物学到全身健康

Journal of Internal Medicine

IF9.2

2025-11-060

OAAI

Elevated levels of salivary interleukin-34 in patients suffering from Alzheimer's disease

阿尔茨海默病患者唾液中白细胞介素-34水平升高

CLINICAL ORAL INVESTIGATIONS

IF3.1

2025-05-200

OA

Intravenous chaperone treatment of late-stage Alzheimers disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes

TRANSLATIONAL PSYCHIATRY

IF6.2

2024-10-242

OAAI

Small Molecule Decoy of Amyloid-(3 Aggregation Blocks Activation of Microglia-Like Cells

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2024-09-242

PRE

Pro-resolving lipid mediator reduces amyloid-β42-induced gene expression in human monocyte-derived microglia

NEURAL REGENERATION RESEARCH

IF6.7

2024-05-170

OAAI

Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2022-08-0110

OAAI

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2022-04-0138

OAAI

Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice

COMMUNICATIONS BIOLOGY

IF5.1

2022-03-2133

OAAI

Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2021-09-2815

OA

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2021-08-2619

OAAI

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2021-06-2945

OAAI

Role of polyunsaturated fatty acids in ischemic stroke-A perspective of specialized pro-resolving mediators

CLINICAL NUTRITION

IF7.4

2021-05-0121

OAAI

Reduced Levels of Plasma Lipoxin A4 Are Associated with Post-Stroke Cognitive Impairment

血浆脂氧素A4水平降低与卒中后认知障碍相关

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2021-01-1912

PREAI

Subgingival microbiota in a population with and without cognitive dysfunction

JOURNAL OF ORAL MICROBIOLOGY

IF5.5

2021-01-1535

OAAI

Receptors for pro-resolving mediators are increased in Alzheimer's disease brain

BRAIN PATHOLOGY

IF6.2

2020-01-2149

OAAI

RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome

RvE1治疗可预防唐氏综合征Ts65Dn小鼠模型的记忆丧失和神经炎症

IF5.1

2020-01-1627

OAAI

Markers of inflammation and depressive symptoms in the elderly with and without Alzheimer's disease

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-12-011

PREAI

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2019-05-0745

PREAI

Association between periodontitis and risk of Alzheimer′s disease, mild cognitive impairment and subjective cognitive decline: A case-control study

JOURNAL OF CLINICAL PERIODONTOLOGY

IF6.8

2018-11-0985

PREAI